Emerald Resources NL

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, NEM.AX has a market cap of 164.1B. Regarding current trading prices, EMR.AX is priced at A$5.85, while NEM.AX trades at A$151.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas NEM.AX's P/E ratio is 14.32. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NEM.AX's ROE of +0.25%. Regarding short-term risk, EMR.AX is more volatile compared to NEM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check NEM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, NST.AX has a market cap of 30.3B. Regarding current trading prices, EMR.AX is priced at A$5.85, while NST.AX trades at A$21.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas NST.AX's P/E ratio is 17.94. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NST.AX's ROE of +0.10%. Regarding short-term risk, EMR.AX is more volatile compared to NST.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check NST.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, EVN.AX has a market cap of 24.7B. Regarding current trading prices, EMR.AX is priced at A$5.85, while EVN.AX trades at A$12.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas EVN.AX's P/E ratio is 18.41. In terms of profitability, EMR.AX's ROE is +0.15%, compared to EVN.AX's ROE of +0.25%. Regarding short-term risk, EMR.AX is less volatile compared to EVN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check EVN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, NCM.AX has a market cap of 20.9B. Regarding current trading prices, EMR.AX is priced at A$5.85, while NCM.AX trades at A$23.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas NCM.AX's P/E ratio is 17.56. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NCM.AX's ROE of +0.07%. Regarding short-term risk, EMR.AX is less volatile compared to NCM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check NCM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, AGG.AX has a market cap of 13.9B. Regarding current trading prices, EMR.AX is priced at A$5.85, while AGG.AX trades at A$6.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas AGG.AX's P/E ratio is 50.08. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AGG.AX's ROE of +0.32%. Regarding short-term risk, EMR.AX is less volatile compared to AGG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check AGG.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, DPM.AX has a market cap of 10.6B. Regarding current trading prices, EMR.AX is priced at A$5.85, while DPM.AX trades at A$47.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas DPM.AX's P/E ratio is 17.18. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DPM.AX's ROE of +0.20%. Regarding short-term risk, EMR.AX is less volatile compared to DPM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DPM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GGP.AX has a market cap of 9.1B. Regarding current trading prices, EMR.AX is priced at A$5.85, while GGP.AX trades at A$13.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GGP.AX's P/E ratio is 7.63. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GGP.AX's ROE of +0.42%. Regarding short-term risk, EMR.AX is less volatile compared to GGP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GGP.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, PRU.AX has a market cap of 7.3B. Regarding current trading prices, EMR.AX is priced at A$5.85, while PRU.AX trades at A$5.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas PRU.AX's P/E ratio is 15.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PRU.AX's ROE of +0.12%. Regarding short-term risk, EMR.AX is less volatile compared to PRU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check PRU.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GMD.AX has a market cap of 6.6B. Regarding current trading prices, EMR.AX is priced at A$5.85, while GMD.AX trades at A$5.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GMD.AX's P/E ratio is 16.40. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GMD.AX's ROE of +0.29%. Regarding short-term risk, EMR.AX is less volatile compared to GMD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GMD.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, RMS.AX has a market cap of 6.5B. Regarding current trading prices, EMR.AX is priced at A$5.85, while RMS.AX trades at A$3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas RMS.AX's P/E ratio is 13.60. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RMS.AX's ROE of +0.10%. Regarding short-term risk, EMR.AX is less volatile compared to RMS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RMS.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, DEG.AX has a market cap of 5.9B. Regarding current trading prices, EMR.AX is priced at A$5.85, while DEG.AX trades at A$2.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas DEG.AX's P/E ratio is -246.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DEG.AX's ROE of -0.02%. Regarding short-term risk, EMR.AX is less volatile compared to DEG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DEG.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, CMM.AX has a market cap of 5.4B. Regarding current trading prices, EMR.AX is priced at A$5.85, while CMM.AX trades at A$11.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas CMM.AX's P/E ratio is 21.80. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CMM.AX's ROE of +0.23%. Regarding short-term risk, EMR.AX is more volatile compared to CMM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check CMM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, RRL.AX has a market cap of 5.3B. Regarding current trading prices, EMR.AX is priced at A$5.85, while RRL.AX trades at A$7.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas RRL.AX's P/E ratio is 11.03. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RRL.AX's ROE of +0.28%. Regarding short-term risk, EMR.AX is less volatile compared to RRL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RRL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, WGX.AX has a market cap of 5.1B. Regarding current trading prices, EMR.AX is priced at A$5.85, while WGX.AX trades at A$5.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas WGX.AX's P/E ratio is 19.85. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WGX.AX's ROE of +0.12%. Regarding short-term risk, EMR.AX is less volatile compared to WGX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WGX.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, VAU.AX has a market cap of 4.7B. Regarding current trading prices, EMR.AX is priced at A$5.85, while VAU.AX trades at A$4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas VAU.AX's P/E ratio is 56.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VAU.AX's ROE of +0.04%. Regarding short-term risk, EMR.AX is more volatile compared to VAU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check VAU.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GOR.AX has a market cap of 3.8B. Regarding current trading prices, EMR.AX is priced at A$5.85, while GOR.AX trades at A$3.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GOR.AX's P/E ratio is 18.32. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GOR.AX's ROE of +0.15%. Regarding short-term risk, EMR.AX is more volatile compared to GOR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GOR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, WAF.AX has a market cap of 3.5B. Regarding current trading prices, EMR.AX is priced at A$5.85, while WAF.AX trades at A$2.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas WAF.AX's P/E ratio is 7.37. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WAF.AX's ROE of +0.42%. Regarding short-term risk, EMR.AX is less volatile compared to WAF.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WAF.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, SSR.AX has a market cap of 3.2B. Regarding current trading prices, EMR.AX is priced at A$5.85, while SSR.AX trades at A$15.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas SSR.AX's P/E ratio is -7.30. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SSR.AX's ROE of +0.02%. Regarding short-term risk, EMR.AX is more volatile compared to SSR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check SSR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, SPR.AX has a market cap of 2.8B. Regarding current trading prices, EMR.AX is priced at A$5.85, while SPR.AX trades at A$2.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas SPR.AX's P/E ratio is -35.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SPR.AX's ROE of -0.41%. Regarding short-term risk, EMR.AX is less volatile compared to SPR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SPR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, OBM.AX has a market cap of 2.6B. Regarding current trading prices, EMR.AX is priced at A$5.85, while OBM.AX trades at A$1.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas OBM.AX's P/E ratio is 11.21. In terms of profitability, EMR.AX's ROE is +0.15%, compared to OBM.AX's ROE of +0.68%. Regarding short-term risk, EMR.AX is less volatile compared to OBM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check OBM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, RSG.AX has a market cap of 2.5B. Regarding current trading prices, EMR.AX is priced at A$5.85, while RSG.AX trades at A$1.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas RSG.AX's P/E ratio is 14.81. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RSG.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is less volatile compared to RSG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RSG.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, PDI.AX has a market cap of 2.4B. Regarding current trading prices, EMR.AX is priced at A$5.85, while PDI.AX trades at A$0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas PDI.AX's P/E ratio is -91.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PDI.AX's ROE of -0.08%. Regarding short-term risk, EMR.AX is less volatile compared to PDI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check PDI.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, RED.AX has a market cap of 2.3B. Regarding current trading prices, EMR.AX is priced at A$5.85, while RED.AX trades at A$0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas RED.AX's P/E ratio is 17.10. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RED.AX's ROE of -0.01%. Regarding short-term risk, EMR.AX is less volatile compared to RED.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RED.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, BGL.AX has a market cap of 2.2B. Regarding current trading prices, EMR.AX is priced at A$5.85, while BGL.AX trades at A$1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas BGL.AX's P/E ratio is -37.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BGL.AX's ROE of -0.07%. Regarding short-term risk, EMR.AX is less volatile compared to BGL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BGL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, ALK.AX has a market cap of 2B. Regarding current trading prices, EMR.AX is priced at A$5.85, while ALK.AX trades at A$1.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas ALK.AX's P/E ratio is 16.39. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ALK.AX's ROE of +0.10%. Regarding short-term risk, EMR.AX is less volatile compared to ALK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check ALK.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, KCN.AX has a market cap of 1.7B. Regarding current trading prices, EMR.AX is priced at A$5.85, while KCN.AX trades at A$6.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas KCN.AX's P/E ratio is 14.39. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KCN.AX's ROE of +0.31%. Regarding short-term risk, EMR.AX is less volatile compared to KCN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KCN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, SLR.AX has a market cap of 1.5B. Regarding current trading prices, EMR.AX is priced at A$5.85, while SLR.AX trades at A$1.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas SLR.AX's P/E ratio is 15.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SLR.AX's ROE of +0.03%. Regarding short-term risk, EMR.AX is less volatile compared to SLR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SLR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, CYL.AX has a market cap of 1.4B. Regarding current trading prices, EMR.AX is priced at A$5.85, while CYL.AX trades at A$5.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas CYL.AX's P/E ratio is 12.71. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CYL.AX's ROE of +0.23%. Regarding short-term risk, EMR.AX is less volatile compared to CYL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check CYL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, PNR.AX has a market cap of 1.3B. Regarding current trading prices, EMR.AX is priced at A$5.85, while PNR.AX trades at A$3.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas PNR.AX's P/E ratio is 11.89. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PNR.AX's ROE of +0.20%. Regarding short-term risk, EMR.AX is less volatile compared to PNR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check PNR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, ORE.AX has a market cap of 1.1B. Regarding current trading prices, EMR.AX is priced at A$5.85, while ORE.AX trades at A$2.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas ORE.AX's P/E ratio is 13.87. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ORE.AX's ROE of +0.21%. Regarding short-term risk, EMR.AX is more volatile compared to ORE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check ORE.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, DTR.AX has a market cap of 870.1M. Regarding current trading prices, EMR.AX is priced at A$5.85, while DTR.AX trades at A$0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas DTR.AX's P/E ratio is -5.75. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DTR.AX's ROE of -0.64%. Regarding short-term risk, EMR.AX is less volatile compared to DTR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DTR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, WC8.AX has a market cap of 834.4M. Regarding current trading prices, EMR.AX is priced at A$5.85, while WC8.AX trades at A$0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas WC8.AX's P/E ratio is -61.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WC8.AX's ROE of -0.02%. Regarding short-term risk, EMR.AX is less volatile compared to WC8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WC8.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, BC8.AX has a market cap of 812.7M. Regarding current trading prices, EMR.AX is priced at A$5.85, while BC8.AX trades at A$1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas BC8.AX's P/E ratio is 55.75. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BC8.AX's ROE of +0.06%. Regarding short-term risk, EMR.AX is less volatile compared to BC8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BC8.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TIE.AX has a market cap of 776.2M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TIE.AX trades at A$0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TIE.AX's P/E ratio is -9.67. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TIE.AX's ROE of +0.02%. Regarding short-term risk, EMR.AX is more volatile compared to TIE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TIE.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, SXG.AX has a market cap of 764.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while SXG.AX trades at A$3.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas SXG.AX's P/E ratio is -86.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SXG.AX's ROE of -0.23%. Regarding short-term risk, EMR.AX is less volatile compared to SXG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SXG.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, SBM.AX has a market cap of 744M. Regarding current trading prices, EMR.AX is priced at A$5.85, while SBM.AX trades at A$0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas SBM.AX's P/E ratio is -10.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SBM.AX's ROE of -0.11%. Regarding short-term risk, EMR.AX is less volatile compared to SBM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SBM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, WIA.AX has a market cap of 694.9M. Regarding current trading prices, EMR.AX is priced at A$5.85, while WIA.AX trades at A$0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas WIA.AX's P/E ratio is -47.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WIA.AX's ROE of -0.18%. Regarding short-term risk, EMR.AX is less volatile compared to WIA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WIA.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, FML.AX has a market cap of 662M. Regarding current trading prices, EMR.AX is priced at A$5.85, while FML.AX trades at A$2.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas FML.AX's P/E ratio is 9.63. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FML.AX's ROE of +0.80%. Regarding short-term risk, EMR.AX is less volatile compared to FML.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FML.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TCG.AX has a market cap of 637.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TCG.AX trades at A$0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TCG.AX's P/E ratio is -30.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TCG.AX's ROE of -0.22%. Regarding short-term risk, EMR.AX is less volatile compared to TCG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TCG.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, MEK.AX has a market cap of 397.7M. Regarding current trading prices, EMR.AX is priced at A$5.85, while MEK.AX trades at A$0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas MEK.AX's P/E ratio is 13.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MEK.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is less volatile compared to MEK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check MEK.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, AUC.AX has a market cap of 390.9M. Regarding current trading prices, EMR.AX is priced at A$5.85, while AUC.AX trades at A$0.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas AUC.AX's P/E ratio is -30.33. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AUC.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is less volatile compared to AUC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check AUC.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, DCN.AX has a market cap of 346.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while DCN.AX trades at A$0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas DCN.AX's P/E ratio is -5.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DCN.AX's ROE of -0.74%. Regarding short-term risk, EMR.AX is less volatile compared to DCN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DCN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, BCN.AX has a market cap of 320.9M. Regarding current trading prices, EMR.AX is priced at A$5.85, while BCN.AX trades at A$2.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas BCN.AX's P/E ratio is 35.75. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BCN.AX's ROE of +0.11%. Regarding short-term risk, EMR.AX is less volatile compared to BCN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BCN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, RXL.AX has a market cap of 308.9M. Regarding current trading prices, EMR.AX is priced at A$5.85, while RXL.AX trades at A$0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas RXL.AX's P/E ratio is -10.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RXL.AX's ROE of -0.16%. Regarding short-term risk, EMR.AX is less volatile compared to RXL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RXL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TBR.AX has a market cap of 276.5M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TBR.AX trades at A$5.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TBR.AX's P/E ratio is 6.35. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TBR.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is less volatile compared to TBR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TBR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, ASL.AX has a market cap of 276M. Regarding current trading prices, EMR.AX is priced at A$5.85, while ASL.AX trades at A$1.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas ASL.AX's P/E ratio is -16.33. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ASL.AX's ROE of -0.37%. Regarding short-term risk, EMR.AX is less volatile compared to ASL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check ASL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, ORR.AX has a market cap of 267.5M. Regarding current trading prices, EMR.AX is priced at A$5.85, while ORR.AX trades at A$0.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas ORR.AX's P/E ratio is -5.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ORR.AX's ROE of -0.49%. Regarding short-term risk, EMR.AX is more volatile compared to ORR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check ORR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GG8.AX has a market cap of 263.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while GG8.AX trades at A$0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GG8.AX's P/E ratio is -36.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GG8.AX's ROE of -0.04%. Regarding short-term risk, EMR.AX is less volatile compared to GG8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GG8.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, ERM.AX has a market cap of 252.9M. Regarding current trading prices, EMR.AX is priced at A$5.85, while ERM.AX trades at A$0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas ERM.AX's P/E ratio is -38.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ERM.AX's ROE of -0.33%. Regarding short-term risk, EMR.AX is less volatile compared to ERM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check ERM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GCY.AX has a market cap of 245.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while GCY.AX trades at A$0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GCY.AX's P/E ratio is -1.47. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GCY.AX's ROE of -0.40%. Regarding short-term risk, EMR.AX is less volatile compared to GCY.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GCY.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TTM.AX has a market cap of 238.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TTM.AX trades at A$0.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TTM.AX's P/E ratio is -41.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TTM.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to TTM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TTM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TGM.AX has a market cap of 237.1M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TGM.AX trades at A$0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TGM.AX's P/E ratio is -20.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TGM.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is less volatile compared to TGM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TGM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, FFX.AX has a market cap of 236.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while FFX.AX trades at A$0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas FFX.AX's P/E ratio is -4.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FFX.AX's ROE of +1.76%. Regarding short-term risk, EMR.AX is less volatile compared to FFX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FFX.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, AAR.AX has a market cap of 236.1M. Regarding current trading prices, EMR.AX is priced at A$5.85, while AAR.AX trades at A$0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas AAR.AX's P/E ratio is -16.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AAR.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is less volatile compared to AAR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check AAR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, STN.AX has a market cap of 230.3M. Regarding current trading prices, EMR.AX is priced at A$5.85, while STN.AX trades at A$0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas STN.AX's P/E ratio is -50.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to STN.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is less volatile compared to STN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check STN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, MGV.AX has a market cap of 227.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while MGV.AX trades at A$0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas MGV.AX's P/E ratio is -38.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MGV.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to MGV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check MGV.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, POL.AX has a market cap of 226M. Regarding current trading prices, EMR.AX is priced at A$5.85, while POL.AX trades at A$0.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas POL.AX's P/E ratio is -2.80. In terms of profitability, EMR.AX's ROE is +0.15%, compared to POL.AX's ROE of -2.88%. Regarding short-term risk, EMR.AX is less volatile compared to POL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check POL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TOR.AX has a market cap of 224M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TOR.AX trades at A$0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TOR.AX's P/E ratio is -22.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TOR.AX's ROE of -0.10%. Regarding short-term risk, EMR.AX is less volatile compared to TOR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TOR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, HAV.AX has a market cap of 221.2M. Regarding current trading prices, EMR.AX is priced at A$5.85, while HAV.AX trades at A$0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas HAV.AX's P/E ratio is -62.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HAV.AX's ROE of -0.06%. Regarding short-term risk, EMR.AX is less volatile compared to HAV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check HAV.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, AS1.AX has a market cap of 216.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while AS1.AX trades at A$0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas AS1.AX's P/E ratio is N/A. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AS1.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is less volatile compared to AS1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check AS1.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, BGD.AX has a market cap of 214M. Regarding current trading prices, EMR.AX is priced at A$5.85, while BGD.AX trades at A$0.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas BGD.AX's P/E ratio is -14.92. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BGD.AX's ROE of -0.88%. Regarding short-term risk, EMR.AX is less volatile compared to BGD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BGD.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, HRN.AX has a market cap of 204.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while HRN.AX trades at A$1.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas HRN.AX's P/E ratio is -115.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HRN.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is less volatile compared to HRN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check HRN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, BTR.AX has a market cap of 198.7M. Regarding current trading prices, EMR.AX is priced at A$5.85, while BTR.AX trades at A$0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas BTR.AX's P/E ratio is -3.45. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BTR.AX's ROE of -0.33%. Regarding short-term risk, EMR.AX is less volatile compared to BTR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BTR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, MRT.AX has a market cap of 194.2M. Regarding current trading prices, EMR.AX is priced at A$5.85, while MRT.AX trades at A$0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas MRT.AX's P/E ratio is -8.28. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MRT.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is less volatile compared to MRT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check MRT.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, HRZ.AX has a market cap of 193.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while HRZ.AX trades at A$0.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas HRZ.AX's P/E ratio is -10.44. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HRZ.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is less volatile compared to HRZ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check HRZ.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, VTM.AX has a market cap of 180.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while VTM.AX trades at A$1.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas VTM.AX's P/E ratio is N/A. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VTM.AX's ROE of -0.26%. Regarding short-term risk, EMR.AX is less volatile compared to VTM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check VTM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, DLI.AX has a market cap of 172.2M. Regarding current trading prices, EMR.AX is priced at A$5.85, while DLI.AX trades at A$0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas DLI.AX's P/E ratio is -24.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DLI.AX's ROE of -0.01%. Regarding short-term risk, EMR.AX is less volatile compared to DLI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DLI.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, LLO.AX has a market cap of 162.5M. Regarding current trading prices, EMR.AX is priced at A$5.85, while LLO.AX trades at A$0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas LLO.AX's P/E ratio is -10.33. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LLO.AX's ROE of -0.01%. Regarding short-term risk, EMR.AX is less volatile compared to LLO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check LLO.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, BRB.AX has a market cap of 158.1M. Regarding current trading prices, EMR.AX is priced at A$5.85, while BRB.AX trades at A$0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas BRB.AX's P/E ratio is 3.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BRB.AX's ROE of +0.05%. Regarding short-term risk, EMR.AX is less volatile compared to BRB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BRB.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, VAL.AX has a market cap of 156.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while VAL.AX trades at A$0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas VAL.AX's P/E ratio is N/A. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VAL.AX's ROE of +0.00%. Regarding short-term risk, EMR.AX is less volatile compared to VAL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check VAL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TSO.AX has a market cap of 152.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TSO.AX trades at A$1.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TSO.AX's P/E ratio is -28.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TSO.AX's ROE of -0.07%. Regarding short-term risk, EMR.AX is less volatile compared to TSO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TSO.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, KAU.AX has a market cap of 151.3M. Regarding current trading prices, EMR.AX is priced at A$5.85, while KAU.AX trades at A$0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas KAU.AX's P/E ratio is 25.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KAU.AX's ROE of +0.03%. Regarding short-term risk, EMR.AX is less volatile compared to KAU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KAU.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GPR.AX has a market cap of 150.7M. Regarding current trading prices, EMR.AX is priced at A$5.85, while GPR.AX trades at A$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GPR.AX's P/E ratio is -4.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GPR.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is more volatile compared to GPR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GPR.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, CY5.AX has a market cap of 146.5M. Regarding current trading prices, EMR.AX is priced at A$5.85, while CY5.AX trades at A$0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas CY5.AX's P/E ratio is -12.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CY5.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is less volatile compared to CY5.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check CY5.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, SKY.AX has a market cap of 141M. Regarding current trading prices, EMR.AX is priced at A$5.85, while SKY.AX trades at A$0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas SKY.AX's P/E ratio is -9.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SKY.AX's ROE of -0.20%. Regarding short-term risk, EMR.AX is less volatile compared to SKY.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SKY.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, RND.AX has a market cap of 135.4M. Regarding current trading prices, EMR.AX is priced at A$5.85, while RND.AX trades at A$2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas RND.AX's P/E ratio is 10.35. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RND.AX's ROE of +0.14%. Regarding short-term risk, EMR.AX is less volatile compared to RND.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RND.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GBZ.AX has a market cap of 131M. Regarding current trading prices, EMR.AX is priced at A$5.85, while GBZ.AX trades at A$0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GBZ.AX's P/E ratio is -2.90. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GBZ.AX's ROE of -0.10%. Regarding short-term risk, EMR.AX is less volatile compared to GBZ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GBZ.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, LSX.AX has a market cap of 130.4M. Regarding current trading prices, EMR.AX is priced at A$5.85, while LSX.AX trades at A$0.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas LSX.AX's P/E ratio is 2.39. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LSX.AX's ROE of +0.38%. Regarding short-term risk, EMR.AX is less volatile compared to LSX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check LSX.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, X64.AX has a market cap of 129.9M. Regarding current trading prices, EMR.AX is priced at A$5.85, while X64.AX trades at A$0.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas X64.AX's P/E ratio is 28.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to X64.AX's ROE of -0.00%. Regarding short-term risk, EMR.AX is more volatile compared to X64.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check X64.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, FXG.AX has a market cap of 128.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while FXG.AX trades at A$0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas FXG.AX's P/E ratio is -26.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FXG.AX's ROE of -0.11%. Regarding short-term risk, EMR.AX is less volatile compared to FXG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FXG.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, LRL.AX has a market cap of 125.9M. Regarding current trading prices, EMR.AX is priced at A$5.85, while LRL.AX trades at A$0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas LRL.AX's P/E ratio is -11.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LRL.AX's ROE of -0.56%. Regarding short-term risk, EMR.AX is less volatile compared to LRL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check LRL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GBM.AX has a market cap of 122.7M. Regarding current trading prices, EMR.AX is priced at A$5.85, while GBM.AX trades at A$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GBM.AX's P/E ratio is -2.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GBM.AX's ROE of +4.59%. Regarding short-term risk, EMR.AX is less volatile compared to GBM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GBM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, KAI.AX has a market cap of 120.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while KAI.AX trades at A$0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas KAI.AX's P/E ratio is -11.83. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KAI.AX's ROE of -0.26%. Regarding short-term risk, EMR.AX is less volatile compared to KAI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KAI.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TUL.AX has a market cap of 116.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TUL.AX trades at A$0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TUL.AX's P/E ratio is -2.88. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TUL.AX's ROE of N/A. Regarding short-term risk, EMR.AX is less volatile compared to TUL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TUL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, MMC.AX has a market cap of 115.1M. Regarding current trading prices, EMR.AX is priced at A$5.85, while MMC.AX trades at A$0.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas MMC.AX's P/E ratio is -11.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MMC.AX's ROE of -0.39%. Regarding short-term risk, EMR.AX is more volatile compared to MMC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check MMC.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TAM.AX has a market cap of 109.3M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TAM.AX trades at A$0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TAM.AX's P/E ratio is -9.30. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TAM.AX's ROE of -0.13%. Regarding short-term risk, EMR.AX is more volatile compared to TAM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TAM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, AQI.AX has a market cap of 106M. Regarding current trading prices, EMR.AX is priced at A$5.85, while AQI.AX trades at A$1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas AQI.AX's P/E ratio is -18.56. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AQI.AX's ROE of -0.45%. Regarding short-term risk, EMR.AX is less volatile compared to AQI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check AQI.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, KGD.AX has a market cap of 96M. Regarding current trading prices, EMR.AX is priced at A$5.85, while KGD.AX trades at A$0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas KGD.AX's P/E ratio is -8.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KGD.AX's ROE of -1.31%. Regarding short-term risk, EMR.AX is less volatile compared to KGD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KGD.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, CAI.AX has a market cap of 93.7M. Regarding current trading prices, EMR.AX is priced at A$5.85, while CAI.AX trades at A$0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas CAI.AX's P/E ratio is -3.83. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CAI.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is less volatile compared to CAI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check CAI.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, FAL.AX has a market cap of 86.3M. Regarding current trading prices, EMR.AX is priced at A$5.85, while FAL.AX trades at A$0.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas FAL.AX's P/E ratio is -16.17. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FAL.AX's ROE of -0.56%. Regarding short-term risk, EMR.AX is more volatile compared to FAL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check FAL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, PTN.AX has a market cap of 85.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while PTN.AX trades at A$0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas PTN.AX's P/E ratio is -5.80. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PTN.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is less volatile compared to PTN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check PTN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, GHM.AX has a market cap of 80M. Regarding current trading prices, EMR.AX is priced at A$5.85, while GHM.AX trades at A$0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas GHM.AX's P/E ratio is -3.21. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GHM.AX's ROE of -0.17%. Regarding short-term risk, EMR.AX is less volatile compared to GHM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GHM.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, TRY.AX has a market cap of 78.9M. Regarding current trading prices, EMR.AX is priced at A$5.85, while TRY.AX trades at A$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas TRY.AX's P/E ratio is -0.74. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TRY.AX's ROE of +4.97%. Regarding short-term risk, EMR.AX is less volatile compared to TRY.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TRY.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, KSN.AX has a market cap of 75.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while KSN.AX trades at A$0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas KSN.AX's P/E ratio is 2.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KSN.AX's ROE of +0.30%. Regarding short-term risk, EMR.AX is less volatile compared to KSN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KSN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, YRL.AX has a market cap of 74.6M. Regarding current trading prices, EMR.AX is priced at A$5.85, while YRL.AX trades at A$0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas YRL.AX's P/E ratio is -11.75. In terms of profitability, EMR.AX's ROE is +0.15%, compared to YRL.AX's ROE of -0.62%. Regarding short-term risk, EMR.AX is less volatile compared to YRL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check YRL.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, WMC.AX has a market cap of 72.7M. Regarding current trading prices, EMR.AX is priced at A$5.85, while WMC.AX trades at A$0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas WMC.AX's P/E ratio is -6.83. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WMC.AX's ROE of +0.15%. Regarding short-term risk, EMR.AX is less volatile compared to WMC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WMC.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, AME.AX has a market cap of 69.5M. Regarding current trading prices, EMR.AX is priced at A$5.85, while AME.AX trades at A$0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas AME.AX's P/E ratio is -9.40. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AME.AX's ROE of -0.06%. Regarding short-term risk, EMR.AX is more volatile compared to AME.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AME.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, KIN.AX has a market cap of 67.2M. Regarding current trading prices, EMR.AX is priced at A$5.85, while KIN.AX trades at A$0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas KIN.AX's P/E ratio is -5.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KIN.AX's ROE of -0.62%. Regarding short-term risk, EMR.AX is less volatile compared to KIN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KIN.AX's competition here

EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EMR.AX stands at 3.9B. In comparison, CHZ.AX has a market cap of 65.8M. Regarding current trading prices, EMR.AX is priced at A$5.85, while CHZ.AX trades at A$0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EMR.AX currently has a P/E ratio of 39.00, whereas CHZ.AX's P/E ratio is -10.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CHZ.AX's ROE of -0.17%. Regarding short-term risk, EMR.AX is more volatile compared to CHZ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check CHZ.AX's competition here